I have looked on several drug sites and cannot find any known interactions of Xyrem(GHB) and Deprenyl.
I want to start taking Deprenyl again because it seemed to make modafinil more effective. I just want to be sure it's safe to do.
Posted 07 August 2010 - 08:45 PM
Posted 08 August 2010 - 07:13 AM
Posted 09 August 2010 - 05:07 PM
Posted 09 August 2010 - 06:54 PM
Old (27-month-old) rats given different doses of D for 1 month showed a typical hormetic response for antioxidant enzyme activities, indicating a significant increase in superoxide dismutase (SOD) and catalase (CAT) activities in brain dopaminergic regions with four lower doses (0.25 to 2 mg/kg/inj., 3 times a week), but a significantly negative response with the highest dose (4 mg/kg/inj.).
Edited by medievil, 09 August 2010 - 07:27 PM.
Posted 09 August 2010 - 07:36 PM
I strongly advice against this combination as deprenyl could severely potentiate neurotoxic damage by GBL.
Old (27-month-old) rats given different doses of D for 1 month showed a typical hormetic response for antioxidant enzyme activities, indicating a significant increase in superoxide dismutase (SOD) and catalase (CAT) activities in brain dopaminergic regions with four lower doses (0.25 to 2 mg/kg/inj., 3 times a week), but a significantly negative response with the highest dose (4 mg/kg/inj.).
A dose of 5mg of deprenyl a day can significantly lower your antioxidant enzymes (and rats arent humans, so its all gueswork) id say taking deprenyl itself is a bad idea if your into neuroprotective substances taking it with neurotoxic substances is stupid imo.
Edited by Animal, 09 August 2010 - 07:36 PM.
Posted 10 August 2010 - 02:22 AM
Rats arent tiny humans, those doses need to be converted to humans, someone here on the forum did the calculation allready, read this:I strongly advice against this combination as deprenyl could severely potentiate neurotoxic damage by GBL.
Old (27-month-old) rats given different doses of D for 1 month showed a typical hormetic response for antioxidant enzyme activities, indicating a significant increase in superoxide dismutase (SOD) and catalase (CAT) activities in brain dopaminergic regions with four lower doses (0.25 to 2 mg/kg/inj., 3 times a week), but a significantly negative response with the highest dose (4 mg/kg/inj.).
A dose of 5mg of deprenyl a day can significantly lower your antioxidant enzymes (and rats arent humans, so its all gueswork) id say taking deprenyl itself is a bad idea if your into neuroprotective substances taking it with neurotoxic substances is stupid imo.
Do you even understand the study you quoted? Deprenyl is neuroprotective in clinical doses, injecting 4mg/kg is an absurdly high dose and is not comparable at all to a human taking 5mg a day orally. Please try to correctly interpret a study before using it as evidence next time.
Maybe the above calculation is incorrect then i rest my case, but now it looks like that 5 mg of deprenyl a day can be harmfull and has a negative effect on the body's antioxidant enzyme's. Humans are also differend from rats so who knows what doses are harmfull and neuroprotective, i would avoid doses higher then 1 mg once a week to promote longevity. (personaly i avoid this substance).I did some math according to Dose translation from animal to human studies revisited
Here is how you do it: HED(mg/kg) = Animal dose (mg/kg) multiplied by (Animal Km / Human Km)
Where Animal Km is for instance 6 for rats and 37 for an adult human of 60 kg (Table 1 in the pdf).
So 0.5 mg/kg, which was too high for a rat would then be the following for a 60 kg adult:
0.5*(6/37)*60=4.86 mg, which would mean that 5 mg of Deprenyl per day is probably too high if taken for longevity!
And 0.25 mg/kg, which seemed to extend life in rats would give us
0.25*(6/37)*60=2.43 mg, which indicates that 2.5 actually seems to be more appropriate dosage for increasing lifespan in humans.
So according to my calculations (which I implore you all to double-check) a dose as low as 5 mg per day of Deprenyl might actually be harmful, at least in the long run. ~0.1-2.5 mg/day seems to be far superior health wise.
Of course one should bear in mind that these are studies on animals and not humans after all.
I haven't found any studies testing whether such a low dose actually has any therapeutic effects in humans (the lowest dosages tested I could find were 5 mg/day, I found one study where they tested 1.25 mg Zydis Selegiline and got results but that one has better bio-availibilty than regular Selegiline it seems so it doesn't really count in my mind). So whether such a low dose as 2.5 mg per day could give statistically significant effects in humans is still up in the air.
Edited by medievil, 10 August 2010 - 02:23 AM.
Posted 10 August 2010 - 03:49 AM
I strongly advice against this combination as deprenyl could severely potentiate neurotoxic damage by GBL.
Old (27-month-old) rats given different doses of D for 1 month showed a typical hormetic response for antioxidant enzyme activities, indicating a significant increase in superoxide dismutase (SOD) and catalase (CAT) activities in brain dopaminergic regions with four lower doses (0.25 to 2 mg/kg/inj., 3 times a week), but a significantly negative response with the highest dose (4 mg/kg/inj.).
A dose of 5mg of deprenyl a day can significantly lower your antioxidant enzymes (and rats arent humans, so its all gueswork) id say taking deprenyl itself is a bad idea if your into neuroprotective substances taking it with neurotoxic substances is stupid imo.
Do you even understand the study you quoted? Deprenyl is neuroprotective in clinical doses, injecting 4mg/kg is an absurdly high dose and is not comparable at all to a human taking 5mg a day orally. Please try to correctly interpret a study before using it as evidence next time.
Posted 10 August 2010 - 08:03 PM
Posted 12 August 2010 - 05:53 AM
There might be a case that 5mg/day in humans could be detrimental to lifespan. And 4mg/kg (~45mg for 70kg human) may cause a decrease in SOD, but lower dosages corresponding to ~5mg/day showed an increase in SOD, so I'm not sure why you're concluding that the putative lifespan-shortening effects at lower dosages are due to this.Maybe the above calculation is incorrect then i rest my case, but now it looks like that 5 mg of deprenyl a day can be harmfull and has a negative effect on the body's antioxidant enzyme's. Humans are also differend from rats so who knows what doses are harmfull and neuroprotective, i would avoid doses higher then 1 mg once a week to promote longevity. (personaly i avoid this substance).
Edited by chrono, 12 August 2010 - 05:54 AM.
Posted 12 August 2010 - 10:27 AM
There's not much info in this abstract about the 1mg/kg doses but the rats began dying earlier so i assumed there was the same detrimental effect on the body's antioxidant enzyme's as 4mg/kg in the old rats. Calculated to humans 1mg/kg is 9mg and that dose is not given everyday but 3 times a week.The necessity of having a proper dose of (-)deprenyl (D) to prolong the life spans of rats explains discrepancies among different studies in the past.
Kitani K, Kanai S, Miyasaka K, Carrillo MC, Ivy GO.
National Institute for Longevity Sciences, Morioka-cho, Obu-shi, Aichi, Japan. kitani@nils.go.jp
Abstract
(-)Deprenyl (D) has been shown to be effective in prolonging life span in experimental animals, although, there are some discrepancies in its effect on the life span the even within the same species (rats). The present study aims to clarify the reason for these discrepancies. Male F344/DuCrj rats began receiving subcutaneous (s.c.) injections of D at the age of 18 months. Doses used were 0.25, 0.50, and 1.0 mg/kg/injection (inj.), three times a week. Average life spans of animals were significantly longer in male rats given 0.25 and 0.5 mg/kg/inj.; however, rats given a 1.0 mg/kg dose began dying earlier than control rats, leading to an inverse U-shaped dose-efficacy relationship, a hormesis. Old (27-month-old) rats given different doses of D for 1 month showed a typical hormetic response for antioxidant enzyme activities, indicating a significant increase in superoxide dismutase (SOD) and catalase (CAT) activities in brain dopaminergic regions with four lower doses (0.25 to 2 mg/kg/inj., 3 times a week), but a significantly negative response with the highest dose (4 mg/kg/inj.). Our results clearly indicate that a proper dose of D within a certain dose range can significantly increase the life span of rats, but that a greater dose becomes less effective and may actually adversely affect the life span of rats. A similar hormetic response for its effect on antioxidant enzyme activities and the parallel between the two different effects of D suggest a possible causal relationship between these two effects of D. The presence of this effective dose range of D may explain previously reported discrepancies in the effect of D on the life span of animals.
Edited by medievil, 12 August 2010 - 10:42 AM.
Posted 12 August 2010 - 11:26 AM
9mg 3 times a day is pretty damn close to 5mg a day.
Posted 12 August 2010 - 12:29 PM
Hmm, seems like you have a point there, i should have factored in the bioavailabilty.9mg 3 times a day is pretty damn close to 5mg a day.
Look up the bioavailabilty of deprenyl when administered orally, 5mg/day taken orally is still in no way comparable to 9mg injected 3 times a week.
Posted 12 August 2010 - 03:51 PM
Right, but in this same abstract, it's showing that 0.25-2mg/kg has a positive effect on antioxidants, so I'm unable to see how that's possible. I'm imagining that the modulation of lifespan is through a different mechanism. I could be wrong, but I don't think this data suggests it.There's not much info in this abstract about the 1mg/kg doses but the rats began dying earlier so i assumed there was the same detrimental effect on the body's antioxidant enzyme's as 4mg/kg in the old rats.
Posted 12 August 2010 - 06:09 PM
Right, but in this same abstract, it's showing that 0.25-2mg/kg has a positive effect on antioxidants, so I'm unable to see how that's possible. I'm imagining that the modulation of lifespan is through a different mechanism. I could be wrong, but I don't think this data suggests it.There's not much info in this abstract about the 1mg/kg doses but the rats began dying earlier so i assumed there was the same detrimental effect on the body's antioxidant enzyme's as 4mg/kg in the old rats.
The present study aims to clarify the reason for these discrepancies. Male F344/DuCrj rats began receiving subcutaneous (s.c.) injections of D at the age of 18 months. Doses used were 0.25, 0.50, and 1.0 mg/kg/injection (inj.), three times a week. Average life spans of animals were significantly longer in male rats given 0.25 and 0.5 mg/kg/inj.; however, rats given a 1.0 mg/kg dose began dying earlier than control rats, leading to an inverse U-shaped dose-efficacy relationship, a hormesis.
Old (27-month-old) rats given different doses of D for 1 month showed a typical hormetic response for antioxidant enzyme activities, indicating a significant increase in superoxide dismutase (SOD) and catalase (CAT) activities in brain dopaminergic regions with four lower doses (0.25 to 2 mg/kg/inj., 3 times a week), but a significantly negative response with the highest dose (4 mg/kg/inj.).
Posted 15 August 2010 - 08:48 PM
Posted 15 August 2010 - 08:56 PM
Posted 15 August 2010 - 10:20 PM
Posted 16 August 2010 - 03:18 AM
Posted 04 June 2011 - 02:57 AM
GHB is neurotoxic due to a excitoxic mechanism...
Posted 04 June 2011 - 06:27 AM
GHB is neurotoxic due to a excitoxic mechanism...
Are you serious? Man you are so off it's not even funny! GHB is close to a miracle drug especially for narcolepsy! The FDA criminalized for Big Pharma since it is an all natural compound, they couldn't patent it until it was given the Schedule 1 status.
http://www.ncbi.nlm....pubmed/17105951
http://www.ceri.com/
Edited by HyperHydrosis, 04 June 2011 - 06:30 AM.
Posted 04 June 2011 - 11:12 AM
In multiple studies, GHB has been found to impair spatial and working learning and memory in rats with chronic administration.[58][59][60][61] These effects are associated with decreased NMDA receptor expression in the cerebral cortex and possibly other areas as well.[58]
Pedraza et al. (2009) found that repeated administration of GHB to rats for 15 days drastically reduced the number of neurons and non-neuronal cells in the CA1 region of the hippocampus and in the prefrontal cortex. With doses of 10 mg/kg of GHB, they were decreased by 61% in the CA1 region and 32% in the prefrontal cortex, and with 100 mg/kg, they were decreased by 38% and 9%, respectively. It is interesting to note that GHB has biphasic effects on neuronal loss, with lower doses (10 mg/kg) producing the most neurotoxicity, and higher doses (100 mg/kg) producing less.
Pretreatment with NCS-382, a GHB receptor antagonist, prevents both learning/memory deficits and neuronal loss in GHB-treated animals, suggesting that GHB's neurotoxic actions are mediated via activation of the GHB receptor.[61] In addition, the neurotoxicity appears to be caused by oxidative stress.
GHB has neuroprotective properties and has been found to protect cells from hypoxia.[42]
Posted 08 February 2012 - 10:01 PM
0 members, 6 guests, 0 anonymous users